The global smart orthopedic implants market size was valued at USD 25.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030. Factors driving market growth include increased research and development initiatives, advancements in orthopedic procedures, and the adoption of enabling technologies such as robotics and surgical navigation. Moreover, the efforts of leading companies are also contributing to this growth.
The rising incidence of chronic diseases such as obesity and diabetes, which increase the risk of degenerative joint diseases, is also contributing to higher demand for orthopedic surgeries and smart implants. Furthermore, technological advancements in smart implant technology, including robotic systems and digital enabling technologies, are enhancing surgical outcomes and patient monitoring, making these products more attractive to healthcare providers.
The market is also driven by the growing preference for minimally invasive surgical techniques, which reduce recovery time and discomfort for patients, and the increased availability of advanced orthopedic solutions. Moreover, improved healthcare infrastructure and increased access to surgical procedures are supporting market growth, particularly in developing regions. Efforts by governments and organizations to raise awareness about treatment options for bone injuries are also influencing patient choices towards smart orthopedic implants.
The integration of Internet of Things (IoT) and Artificial Intelligence (AI) technology in orthopedic implants enables close monitoring of patient health, detecting movement, implant condition, and rate of recovery. This allows for prompt initiation of proper treatment. Advances in biomaterial fabrication also enhance the compatibility of implants with the human body, further driving market growth. With the global population aging, orthopedic issues such as osteoarthritis, osteoporosis, and fractures are becoming increasingly common. As a result, there is a growing need for better orthopedic services that facilitate quick healing processes, driving demand for smart orthopedic implants.
The knee segment dominated the market with a revenue share of 46.8% in 2023. The global prevalence of knee disorders, including osteoarthritis, rheumatoid arthritis, and sports injuries, has a significant impact on mobility and overall well-being. According to the World Health Organization (WHO), 73% of osteoarthritis patients are over 55 years old, with 60% being women. This demographic presents a significant market opportunity for knee-related treatments and solutions.
The hip application segment is expected to register the fastest CAGR of 5.1% during the forecast period, driven by the increasing age of the global population. As individuals age, their immune defenses decline, making them more susceptible to hip joint disorders and illnesses, such as osteoarthritis and fractures. With the world’s population projected to reach 2 billion by 2050 by the WHO, the demand for hip-related treatments and solutions is expected to rise.
The implants segment led the market with a revenue share of 82.7% in 2023. The integration of sensors, wireless connectivity, and advanced materials has transformed conventional orthopedic implants into smart devices. This innovation enables real-time patient health monitoring, streamlining post-surgery care and reducing recovery times. The emphasis on optimizing patient outcomes is also driving growth in the implants component segment.
The electronic components segment is expected to register the fastest CAGR of 6.5% during the forecast period. Smart orthopedic implants, equipped with electronic interfaces, are increasingly used in patient rehabilitation. These implants feature alerts, such as notifications for physical therapy exercises, ensuring timely adherence to rehabilitation schedules. Moreover, collected data is analyzed to monitor long-term implant behavior and patient health trends, enabling more informed treatment decisions and improved patient outcomes.
Total replacement procedures held the largest revenue share of 56.9% in 2023, owing to the rising prevalence of orthopedic diseases, increased joint replacement surgeries, and technological advancements. With the global total knee replacement market growing, smart implants with embedded sensors offer enhanced post-operative healing, reduced implant failure rates, and improved patient satisfaction.
Partial replacement procedures are expected to register the fastest CAGR of 5.2% during the forecast period. By targeting only the damaged joint area, surgeons can restore healthy tissues and bones, reducing recovery time and pain for patients. Partial replacement procedures are also more cost-effective for healthcare systems and patients compared to total joint replacements, making them a more economical and efficient option.
The hospitals segment dominated the market with a revenue share of 68.0% in 2023, fueled by the growing number of surgical procedures annually. Hospitals, with their advanced infrastructures and skilled personnel, are well-suited to integrate smart implants. Their existing infrastructure and capabilities enable them to seamlessly adopt smart technologies, enhancing patient care and service delivery.
The others (ASCs, Research Institutes) segment is expected to register the fastest CAGR of 5.4% during the forecast period. Ambulatory Surgical Centers (ASCs) have successfully performed orthopedic procedures, demonstrating efficiency and cost-effectiveness. With lower operational costs, ASCs offer competitive pricing, making it accessible to more patients. Meanwhile, research institutions are driving innovation in smart orthopedic implants, developing new technologies and materials that will shape the industry’s future.
North America smart orthopedic implants market dominated the global smart orthopedic implants market with a revenue share of 41.8% in 2023. The region’s significant share is attributed to the presence of leading companies, such as Zimmer Biomet, and the widespread adoption of digital technologies and robotic systems in healthcare. The growing prevalence of orthopedic disorders is expected to drive regional growth in the coming years, further solidifying the region’s position.
The smart orthopedic implants market in U.S. dominated the North America smart orthopedic implants market with a revenue share of 81.4% in 2023. The country’s dominance can be attributed to a combination of factors, including technological advancements, healthcare infrastructure, regulatory environment, and market dynamics. In the U.S., arthritis is a prevalent chronic condition, with doctors identifying it as a major cause of disability. By 2040, 78.4 million adults are projected to be affected.
Asia Pacific smart orthopedic implants market is expected to register the fastest CAGR of 6.1% in the forecast period. The Asia Pacific region is driving innovation in smart orthopedic implants and medical technologies. Countries such as Japan, China, and India have invested heavily in R&D, resulting in the development of advanced products that enhance patient quality of life and position the region as a leader in this space.
The smart orthopedic implants market in Japan dominated the Asia Pacific smart orthopedic implants market with revenue share of 21.5% in 2023. Japan is a prominent global player in technology and engineering, ranking among the top countries in R&D expenditure. This significant investment in various sectors, including healthcare, fosters collaboration between universities, research centers, and private corporations, driving advancements in medical technologies and positioning Japan as a leader in innovation.
Europe smart orthopedic implants market held substantial market share in 2023. Europe is renowned for its exceptional healthcare systems, with countries such as Germany, France, and the UK boasting well-established hospitals that seamlessly integrate modern technologies. This robust infrastructure fosters innovation, driving the development of cutting-edge devices such as smart orthopedic implants.
The smart orthopedic implants market in Germany is expected to grow in the forecast period. Germany’s rapidly growing aging population has created a significant demand for smart orthopedic implants, driving the market’s upward trajectory. The German government actively supports innovation in the medical device sector through targeted funding initiatives and research programs, promoting the development of health technologies and fueling market growth.
Some key companies in the smart orthopedic implants market include Zimmer Biomet; Medtronic; Boston Scientific Corporation; and others. In response to intensifying competition, market players have employed strategies such as new product introductions, expanded distribution channels, and geographical expansion to stay ahead.
Zimmer Biomet Holdings Inc. specializes in designing, manufacturing, and marketing orthopedic implants. The company prioritizes innovation, leveraging data to drive smarter operations and revolutionize orthopedic surgery.
Medtronic offers comprehensive services and solutions. The company has made significant strides in developing cutting-edge smart orthopedic implants, providing real-time status information to clinicians to improve patient outcomes.
The following are the leading companies in the smart orthopedic implants market. These companies collectively hold the largest market share and dictate industry trends.
In July 2024, Stryker completed the acquisition of Artelon, a strategic move that bolstered its product portfolio and expanded its capabilities in the orthopedic and surgical markets, aligning with its commitment to product excellence.
In May 2024, Exactech launched its latest ligament-driven balancing technology, ExactechGPS, with new software and modern alignment philosophies for total knee replacement surgery.
Report Attribute |
Details |
Market size value in 2024 |
USD 26.6 billion |
Revenue forecast in 2030 |
USD 34.8 billion |
Growth rate |
CAGR of 4.5% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, component, procedure, end use, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Zimmer Biomet; Medtronic; Boston Scientific Corporation; Abbott; NEVRO CORP; Biotronik; Cochlear Ltd.; Exactech, Inc.; Stryker; CONMED Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global smart orthopedic implants market report based on application, component, procedure, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Expression Systems
E. coli Cell-free Protein Expression System
Wheat Germ Cell-free Protein Expression System
Rabbit Reticulocytes Cell-free Protein Expression System
Insect Cells Cell-free Protein Expression System
Human Cell-free Protein Expression System
Others
Reagents
Application Outlook (Revenue, USD Million, 2018 - 2030)
Enzyme Engineering
High Throughput Production
Protein Labeling
Protein-Protein Interaction
Protein Purification
Method Outlook (Revenue, USD Million, 2018 - 2030)
Transcription & Translation systems
Translation systems
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."